by Ubaka Ogbogu | Jul 12, 2010
On June 30, the Canadian Institutes of Health Research (CIHR) released updated Guidelines for Human Pluripotent Stem Cell Research. The Guidelines apply to all research involving human pluripotent stem cells conducted with funding from, or under the auspices of...
by Katie Moisse | Jun 4, 2010
The UK-based Motor Neurone Disease Association has recently funded a £800,000 ($1.2 million) program to study motor neurons derived from the skin cells of amyotrophic lateral sclerosis (ALS) patients with rare, disease-causing mutations in the gene TARBP. Although the...
by Paul Krzyzanowski | May 11, 2010
Imagine that you’ve just discovered a novel drug that potentially solves a medical problem, one that accelerates wound healing in skin or can reduce the size of cancerous tumors. You can show the effects beautifully in your model tissue culture system and mice...
by Stem Cell Network | Jan 19, 2010
The journal Nature Methods recently announced induced pluripotent stem cells as Method of the Year 2009 for its potential for biological discovery. In the few short years since their discovery by Japanese researcher Shinya Yamanaka, iPS cells have become one of the...
by Michael Rudnicki | Dec 11, 2009
iPS cells give us an unprecedented opportunity to create patient- and disease-specific cells. Labs around the world have demonstrated that iPS cells can generate disease-specific cells for illnesses such as muscular dystrophy, Parkinson’s and type 1 diabetes, among...
Comments